Literature DB >> 14635063

Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients.

Amy C Degnim1, Kent A Griffith, Michael S Sabel, Daniel F Hayes, Vincent M Cimmino, Kathleen M Diehl, Peter C Lucas, Matthew L Snyder, Alfred E Chang, Lisa A Newman.   

Abstract

BACKGROUND: In breast carcinoma patients with a positive sentinel lymph node (SN), the value of complete axillary lymph node dissection has been questioned. Multiple published reports have attempted to identify clinicopathologic characteristics of the primary tumor and SN that are associated with an increased likelihood of positive nonsentinel lymph nodes (NSN). Because of differences in lymph node evaluation techniques and limited patient numbers in each study, the authors performed a meta-analysis to assess the regularity and relative strength of association between various characteristics and the risk of NSN metastasis.
METHODS: A MEDLINE search identified 15 candidate studies, 11 of which met the criteria for analysis. General elements of the studies, the pathologic characteristics evaluated, and the results for selected characteristics were compared. Original data were abstracted from each study and used to calculate odds ratios. The Mantel-Haenszel common odds ratios were calculated to determine the relative strength of the associations.
RESULTS: Despite methodologic differences, the correlation between positive NSNs and certain pathologic characteristics was found to be remarkably similar among studies. The 5 individual characteristics found to be associated with the highest likelihood of NSN metastasis are SN metastasis > 2 mm in size, extranodal extension in the SN, tumor size > 2 cm, > 1 positive SN, and lymphovascular invasion in the primary tumor.
CONCLUSIONS: There is general concordance among studies regarding the association between pathologic characteristics and NSN metastasis in breast carcinoma patients with a positive SN. The pooled analysis identified those factors with the strongest associations that should be evaluated routinely in SN specimens and included in prospective databases for the development of a predictive model. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2003        PMID: 14635063     DOI: 10.1002/cncr.11803

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

Review 1.  Sentinel lymph node mapping for primary breast cancer.

Authors:  Lori L Wilson; Armando E Giuliano
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 2.  Minimal disease in sentinel nodes.

Authors:  Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

3.  The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the "Hôpital Tenon" score revisited. A two-institution study.

Authors:  I Barco; A García-Fernández; C Chabrera; M Fraile; E Vallejo; J M Lain; J Deu; S González; C González; E Veloso; J Torres; M Torras; L Cirera; A Pessarrodona; N Giménez; M García-Font
Journal:  Clin Transl Oncol       Date:  2016-02-26       Impact factor: 3.405

4.  Axillary Lymph Node Status in Early-Stage Breast Cancer Patients with Sentinel Node Micrometastases (0.2-2 mm).

Authors:  Johannes Bargehr; Michael Edlinger; Michael Hubalek; Christian Marth; Roland Reitsamer
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

5.  Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.

Authors:  Giuseppe Viale; Eugenio Maiorano; Giancarlo Pruneri; Mauro G Mastropasqua; Stefano Valentini; Viviana Galimberti; Stefano Zurrida; Patrick Maisonneuve; Giovanni Paganelli; Giovanni Mazzarol
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

6.  In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement.

Authors:  Ildiko Illyes; Anna-Maria Tokes; Attila Kovacs; A Marcell Szasz; Bela A Molnar; Istvan A Molnar; Ilona Kaszas; Zsuzsanna Baranyak; Zsolt Laszlo; Istvan Kenessey; Janina Kulka
Journal:  Virchows Arch       Date:  2014-05-09       Impact factor: 4.064

Review 7.  Breast cancer: Actual methods of treatment and future trends.

Authors:  Paweł Murawa; Dawid Murawa; Beata Adamczyk; Karol Połom
Journal:  Rep Pract Oncol Radiother       Date:  2014-01-23

8.  Patients' choice on axillary lymph node dissection following sentinel lymph node micrometastasis--first report on prospective use of a nomogram in very low risk patients.

Authors:  Gábor Cserni; Istvánné Bezsenyi; László Markó
Journal:  Pathol Oncol Res       Date:  2012-10-16       Impact factor: 3.201

9.  Eight-year experience with the intraoperative frozen section examination of sentinel lymph node biopsy for breast cancer in a North-Italian university center.

Authors:  Carla Cedolini; Serena Bertozzi; Luca Seriau; Ambrogio P Londero; Serena Concina; Federico Cattin; Onelio Geatti; Carla Di Loreto; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

10.  Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.

Authors:  Naveen Padmanabhan; Muhamed Faizal Ayub; Khadher Hussain; Ann Kurien; Selvi Radhakrishna
Journal:  Indian J Surg Oncol       Date:  2015-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.